Physician profile
Edward E Barton
NPI 1174539167
$17,560.04
in general payments reported to CMS, 2019-2025
19 companies · $25.67 in 2025
The $25.67 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,842 · 2020: $4,194 · 2021: $1,949 · 2022: $1,543 · 2023: $183 · 2024: $825 · 2025: $25.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $811 · Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $811.00 |
| Food and Beverage | $221.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Great Lakes Medical Services, LLC | $16,835.00 | 2019-2024 | |
| Boston Scientific Corporation | $173.66 | 2019-2025 | Watchman Flx |
| Rochester Medical Corporation | $88.00 | 2019-2022 | |
| Astellas Pharma US INC | $73.38 | 2022-2023 | Myrbetriq |
| Myovant Sciences INC. | $48.72 | 2021-2022 | |
| Blue Earth Diagnostics | $42.70 | 2021 | |
| Endo Pharmaceuticals INC. | $36.30 | 2022 | |
| Urovant Sciences INC | $35.96 | 2021-2022 | |
| Abbvie INC. | $34.10 | 2023-2024 | Lupron Depot |
| Alnylam Pharmaceuticals INC. | $25.21 | 2023 | Oxlumo |
| Teleflex LLC | $24.10 | 2023 | Urolift |
| Janssen Biotech, INC. | $22.15 | 2023 | |
| Medtronic USA, INC. | $20.14 | 2020 | |
| Convatec INC. | $18.63 | 2022 | |
| 180 Medical, INC. | $18.28 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $17.35 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.31 | 2023 | Yonsa |
| Amgen INC. | $14.72 | 2019 | |
| Laborie Medical Technologies Corp. | $14.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$61,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.